Quality Control of Chinese Medicines: Strategies and Methods

Shaoping Li is a distinguished professor in Quality Control of Chinese Medicines and deputy director at the State Key Laboratory of Quality Research in Chinese Medicine and director of Macao Centre for Testing of Chinese Medicine, University of Macau. Dr. Li was selected in the Power List 2020: Around the World in 60 Scientists, as an expert in herbal glycoanalysis and the development of quality control methods for Chinese medicines, by analytical scientists. He is also a member of USP's Herbal Medicines Compendium--East Asia Expert Panel, an advisor of American Herbal Pharmacopoeia and a member of the Chinese Pharmacopoeia Commission. His research focuses on quality control and active components of Chinese medicines. He has published 6 books in USA and China, including Pharmacological Activity-based Quality Control of Chinese Herbs, and is also the author of over 300 peer-refereed journal papers and book chapters and holder of more than 20 China and US patents.

Jing Zhao, the National Young Qihuang Scholar of China, is an associate professor and Ph.D. supervisor of the State Key Laboratory of Quality Research in Chinese Medicine, University of Macau and the duty director of Joint Laboratory of Chinese Herbal Glycoengineering and Testing Technology, University of Macau & National Glycoengineering Research Center of China. Dr. Zhao obtained her Ph.D. degree in Pharmacognosy from China Pharmaceutical University; she is also the member of executive committee of the Collaborative Lab of the United States Pharmacopoeia Convention and University of Macau. As a specialist in quality control of Chinese medicines, she proposed the strategies of chemical standards industrialization, virtual chemical standards development for Chinese medicines and traditional Chinese medicinal materials futures. Dr. Zhao held more than more than 20 research grants with international, national, ministerial, and provincial levels. At present, Dr. Zhao focuses on thestandardization (technology-oriented) and economic evaluation (management-oriented) of Chinese medicines resources. She has published more than 200 papers including 160 SCI papers and 3 books and holds 10 invention patents.

李少平（Shaoping Li）是澳門大學中藥質量研究國家重點實驗室的質量控制專家、副主任，以及澳門中藥檢測中心的主任。李博士被分析科學家選為2020年「全球60位科學家名單」中的專家，因其在中藥糖基分析和中藥質量控制方法開發方面的專業知識。他還是美國藥典委員會中藥藥典東亞專家小組的成員，美國中草藥藥典的顧問，以及中國藥典委員會的成員。他的研究主要集中在中藥質量控制和活性成分方面。他在美國和中國出版了6本書，包括《中草藥藥理活性質量控制》。此外，他還發表了300多篇同行評審的期刊論文和專書章節，並擁有20多項中國和美國的專利。

趙靜（Jing Zhao）是中國國家青年啟黃學者，澳門大學中藥質量研究國家重點實驗室的副教授和博士生導師，以及澳門大學與中國國家糖工程研究中心合作的中藥糖工程與檢測技術聯合實驗室的負責人。趙博士在中藥質量控制方面是專家，她提出了中藥化學標準產業化、中藥虛擬化學標準開發和中藥材期貨等策略。她獲得了國際、國家、部級和省級的20多項研究項目資助。目前，趙博士的研究重點是中藥資源的標準化（技術導向）和經濟評價（管理導向）。她發表了200多篇論文，包括160篇SCI論文和3本書，並擁有10項發明專利。